Vericel Corporation (VCEL)
USD 39.25
(-6.37%)
USD 39.25
(-6.37%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 135.57 Million USD | 23.49% |
| 2022 | 109.78 Million USD | 3.55% |
| 2021 | 106.02 Million USD | 25.88% |
| 2020 | 84.22 Million USD | 4.92% |
| 2019 | 80.27 Million USD | 36.77% |
| 2018 | 58.69 Million USD | 74.85% |
| 2017 | 33.57 Million USD | 28.74% |
| 2016 | 26.07 Million USD | 5.58% |
| 2015 | 24.69 Million USD | 114.71% |
| 2014 | 11.5 Million USD | 76586.67% |
| 2013 | 15 Thousand USD | 0.0% |
| 2012 | 15 Thousand USD | 7.14% |
| 2011 | 14 Thousand USD | -74.55% |
| 2010 | 55 Thousand USD | -21.43% |
| 2009 | 70 Thousand USD | -84.98% |
| 2008 | 466 Thousand USD | -28.96% |
| 2007 | 656 Thousand USD | -23.0% |
| 2006 | 852 Thousand USD | 11.96% |
| 2005 | 761 Thousand USD | -25.54% |
| 2004 | 1.02 Million USD | 2185.71% |
| 2003 | -49 Thousand USD | -107.26% |
| 2002 | 675 Thousand USD | -23.81% |
| 2001 | 886 Thousand USD | 295.54% |
| 2000 | 224 Thousand USD | -74.4% |
| 1999 | 875 Thousand USD | 251.41% |
| 1998 | 249 Thousand USD | -72.33% |
| 1997 | 900 Thousand USD | 111.25% |
| 1996 | -8 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 36.6 Million USD | 3.53% |
| 2024 Q1 | 35.35 Million USD | -27.12% |
| 2023 Q1 | 26.52 Million USD | -30.66% |
| 2023 FY | 135.57 Million USD | 23.49% |
| 2023 Q4 | 48.5 Million USD | 58.48% |
| 2023 Q3 | 30.6 Million USD | 2.23% |
| 2023 Q2 | 29.94 Million USD | 12.9% |
| 2022 Q1 | 23.45 Million USD | -31.09% |
| 2022 Q2 | 22.85 Million USD | -2.55% |
| 2022 Q3 | 25.23 Million USD | 10.41% |
| 2022 Q4 | 38.24 Million USD | 51.58% |
| 2022 FY | 109.78 Million USD | 3.55% |
| 2021 Q1 | 22.98 Million USD | -31.69% |
| 2021 Q4 | 34.03 Million USD | 54.0% |
| 2021 FY | 106.02 Million USD | 25.88% |
| 2021 Q3 | 22.09 Million USD | -17.88% |
| 2021 Q2 | 26.91 Million USD | 17.08% |
| 2020 Q2 | 11.35 Million USD | -32.24% |
| 2020 Q1 | 16.75 Million USD | -41.83% |
| 2020 Q3 | 22.47 Million USD | 97.91% |
| 2020 Q4 | 33.64 Million USD | 49.74% |
| 2020 FY | 84.22 Million USD | 4.92% |
| 2019 Q2 | 17.12 Million USD | 30.06% |
| 2019 Q3 | 21.17 Million USD | 23.62% |
| 2019 Q4 | 28.8 Million USD | 36.03% |
| 2019 FY | 80.27 Million USD | 36.77% |
| 2019 Q1 | 13.17 Million USD | -42.0% |
| 2018 Q2 | 11.28 Million USD | 8.91% |
| 2018 Q3 | 14.34 Million USD | 27.14% |
| 2018 FY | 58.69 Million USD | 74.85% |
| 2018 Q4 | 22.7 Million USD | 58.27% |
| 2018 Q1 | 10.36 Million USD | -30.75% |
| 2017 FY | 33.57 Million USD | 28.74% |
| 2017 Q4 | 14.96 Million USD | 111.49% |
| 2017 Q1 | 2.25 Million USD | -74.79% |
| 2017 Q2 | 9.28 Million USD | 312.21% |
| 2017 Q3 | 7.07 Million USD | -23.8% |
| 2016 Q4 | 8.93 Million USD | 119.3% |
| 2016 Q2 | 5.52 Million USD | -26.83% |
| 2016 Q1 | 7.54 Million USD | -7.85% |
| 2016 FY | 26.07 Million USD | 5.58% |
| 2016 Q3 | 4.07 Million USD | -26.25% |
| 2015 Q4 | 8.19 Million USD | 80.54% |
| 2015 FY | 24.69 Million USD | 114.71% |
| 2015 Q3 | 4.53 Million USD | -32.17% |
| 2015 Q2 | 6.68 Million USD | 26.66% |
| 2015 Q1 | 5.28 Million USD | -33.61% |
| 2014 Q1 | - USD | -100.0% |
| 2014 FY | 11.5 Million USD | 76586.67% |
| 2014 Q4 | 7.95 Million USD | 92.78% |
| 2014 Q3 | 4.12 Million USD | 815.08% |
| 2014 Q2 | -577 Thousand USD | 0.0% |
| 2013 FY | 15 Thousand USD | 0.0% |
| 2013 Q1 | 6000.00 USD | -60.0% |
| 2013 Q3 | - USD | -100.0% |
| 2013 Q2 | 2000.00 USD | -66.67% |
| 2013 Q4 | 7000.00 USD | 0.0% |
| 2012 Q1 | - USD | -100.0% |
| 2012 Q4 | 15 Thousand USD | 114.29% |
| 2012 FY | 15 Thousand USD | 7.14% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | 7000.00 USD | 0.0% |
| 2011 FY | 14 Thousand USD | -74.55% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 7000.00 USD | 0.0% |
| 2011 Q4 | 452 Thousand USD | 6357.14% |
| 2011 Q3 | 7000.00 USD | 0.0% |
| 2010 FY | 55 Thousand USD | -21.43% |
| 2010 Q3 | - USD | 100.0% |
| 2010 Q2 | -55 Thousand USD | 0.0% |
| 2010 Q1 | - USD | -100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q2 | 4000.00 USD | -87.88% |
| 2009 Q1 | 33 Thousand USD | 230.0% |
| 2009 Q4 | 14 Thousand USD | -65.85% |
| 2009 Q3 | 41 Thousand USD | 925.0% |
| 2009 FY | 70 Thousand USD | -84.98% |
| 2008 Q2 | 124 Thousand USD | -27.91% |
| 2008 Q1 | 172 Thousand USD | 107.23% |
| 2008 FY | 466 Thousand USD | -28.96% |
| 2008 Q4 | 10 Thousand USD | -56.52% |
| 2008 Q3 | 23 Thousand USD | -81.45% |
| 2007 Q2 | 153 Thousand USD | -37.3% |
| 2007 Q1 | 244 Thousand USD | 57.42% |
| 2007 Q4 | 83 Thousand USD | -4.6% |
| 2007 FY | 656 Thousand USD | -23.0% |
| 2007 Q3 | 87 Thousand USD | -43.14% |
| 2006 Q4 | 155 Thousand USD | 49.04% |
| 2006 FY | 852 Thousand USD | 11.96% |
| 2006 Q3 | 104 Thousand USD | -68.29% |
| 2006 Q1 | 236 Thousand USD | 108.85% |
| 2006 Q2 | 328 Thousand USD | 38.98% |
| 2005 Q2 | 88 Thousand USD | -46.99% |
| 2005 FY | 761 Thousand USD | -25.54% |
| 2005 Q4 | 113 Thousand USD | -35.43% |
| 2005 Q3 | 175 Thousand USD | 98.86% |
| 2005 Q1 | 166 Thousand USD | -50.45% |
| 2004 Q4 | 335 Thousand USD | 94.77% |
| 2004 Q3 | 172 Thousand USD | -16.1% |
| 2004 Q2 | 205 Thousand USD | -50.12% |
| 2004 Q1 | 411 Thousand USD | 10.78% |
| 2004 FY | 1.02 Million USD | 2185.71% |
| 2003 Q1 | 75 Thousand USD | 167.57% |
| 2003 FY | -49 Thousand USD | -107.26% |
| 2003 Q3 | 35 Thousand USD | 124.82% |
| 2003 Q4 | 371 Thousand USD | 960.0% |
| 2003 Q2 | -141 Thousand USD | -288.0% |
| 2002 FY | 675 Thousand USD | -23.81% |
| 2002 Q2 | 171 Thousand USD | -10.94% |
| 2002 Q3 | 5000.00 USD | -97.08% |
| 2002 Q4 | -111 Thousand USD | -2320.0% |
| 2002 Q1 | 192 Thousand USD | -4.48% |
| 2001 Q3 | 111 Thousand USD | -56.13% |
| 2001 Q4 | 201 Thousand USD | 81.08% |
| 2001 Q1 | 191 Thousand USD | -32.27% |
| 2001 Q2 | 253 Thousand USD | 32.46% |
| 2001 FY | 886 Thousand USD | 295.54% |
| 2000 Q1 | 327 Thousand USD | -14.62% |
| 2000 Q4 | 282 Thousand USD | 68.86% |
| 2000 Q3 | 167 Thousand USD | -9.24% |
| 2000 Q2 | 184 Thousand USD | -43.73% |
| 2000 FY | 224 Thousand USD | -74.4% |
| 1999 Q1 | 251 Thousand USD | 21.26% |
| 1999 Q3 | -845 Thousand USD | -425.0% |
| 1999 Q4 | 383 Thousand USD | 145.33% |
| 1999 FY | 875 Thousand USD | 251.41% |
| 1999 Q2 | 260 Thousand USD | 3.59% |
| 1998 Q2 | 104 Thousand USD | 30.0% |
| 1998 Q3 | 163 Thousand USD | 56.73% |
| 1998 Q4 | 207 Thousand USD | 26.99% |
| 1998 FY | 249 Thousand USD | -72.33% |
| 1998 Q1 | 80 Thousand USD | 63.27% |
| 1997 FY | 900 Thousand USD | 111.25% |
| 1997 Q4 | 49 Thousand USD | 206.25% |
| 1997 Q1 | 200 Thousand USD | 0.0% |
| 1997 Q2 | 200 Thousand USD | 0.0% |
| 1997 Q3 | 16 Thousand USD | -92.0% |
| 1996 Q3 | 300 Thousand USD | 0.0% |
| 1996 FY | -8 Million USD | 0.0% |
| 1996 Q4 | 200 Thousand USD | -33.33% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | -256.544% |
| Alkermes plc | 1.37 Billion USD | 90.138% |
| Agenus Inc. | 139.61 Million USD | 2.893% |
| Aptorum Group Limited | -1.11 Million USD | 12262.686% |
| Ardelyx, Inc. | 106.66 Million USD | -27.109% |
| Dyadic International, Inc. | 922.95 Thousand USD | -14589.308% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -543.73% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 77641.566% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 1114.954% |
| Novavax, Inc. | 639.93 Million USD | 78.814% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 389.451% |
| Pyxis Oncology, Inc. | -2 Million USD | 6878.8% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 26336.488% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -611.947% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 306916.33% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 25825.996% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 238.037% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -16804.738% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 165436.585% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | -0.227% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1622.475% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 239.841% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 91.068% |
| AlloVir, Inc. | -398 Thousand USD | 34164.322% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 43.682% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -31875.472% |
| Bicycle Therapeutics plc | -129.52 Million USD | 204.676% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -112880.0% |
| ChromaDex Corporation | 50.78 Million USD | -166.987% |
| Chimerix, Inc. | 324 Thousand USD | -41744.444% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 534.989% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 274.716% |
| CRISPR Therapeutics AG | 240.95 Million USD | 43.734% |
| Precision BioSciences, Inc. | 40.47 Million USD | -234.987% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 238.113% |
| Fortress Biotech, Inc. | 57.85 Million USD | -134.346% |
| Fortress Biotech, Inc. | 57.85 Million USD | -134.346% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -717.856% |
| ImmuCell Corporation | 4.39 Million USD | -2983.877% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 227.754% |
| Immix Biopharma, Inc. | -5468.00 USD | 2479544.038% |
| Incyte Corporation | 3.44 Billion USD | 96.06% |
| Innoviva, Inc. | 261.06 Million USD | 48.068% |
| IO Biotech, Inc. | -756 Thousand USD | 18033.333% |
| Jaguar Health, Inc. | 7.72 Million USD | -1655.256% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 20518.072% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | -13.213% |
| ContextLogic Inc. | 59 Million USD | -129.79% |
| MiMedx Group, Inc. | 266.84 Million USD | 49.193% |
| MEI Pharma, Inc. | 49.32 Million USD | -174.852% |
| NextCure, Inc. | -3.68 Million USD | 3780.13% |
| Onconetix, Inc. | -1.12 Million USD | 12128.053% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 568.02% |
| Opthea Limited | 21.72 Thousand USD | -624098.895% |
| Psyence Biomedical Ltd. | -240.00 USD | 56490100.0% |
| Vaxcyte, Inc. | -75 Million USD | 280.768% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 236600.017% |
| Precigen, Inc. | 106 Thousand USD | -127801.887% |
| Pharming Group N.V. | 220.1 Million USD | 38.404% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -26225.437% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -13336.67% |
| PureTech Health plc | -1.6 Million USD | 8557.642% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | -23.507% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 174.735% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 399.12% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 716.619% |
| Acelyrin, Inc. | -115 Thousand USD | 117992.174% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1348980.708% |
| Summit Therapeutics Inc. | -2.05 Million USD | 6713.463% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 23843.608% |
| Senti Biosciences, Inc. | -2.68 Million USD | 5153.149% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -3246.729% |
| Elevation Oncology, Inc. | -39 Thousand USD | 347730.769% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2925.677% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 3539.228% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -365.433% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -27233.871% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 246601.818% |
| Wave Life Sciences Ltd. | 104.09 Million USD | -30.238% |
| Seer, Inc. | 7.02 Million USD | -1829.358% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2996.757% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -529.269% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 114518.817% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 94709.249% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -22162.069% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | -12.535% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 56.778% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2711620.0% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -5167.133% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 267297.477% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -361.347% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 58537.931% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 27656.098% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 2010.059% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 28669.683% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1303715.385% |
| Soligenix, Inc. | 97.31 Thousand USD | -139222.379% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1354.288% |
| Kura Oncology, Inc. | -849 Thousand USD | 16068.905% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 302.039% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 92328.571% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -36.892% |
| Autolus Therapeutics plc | -4.86 Million USD | 2885.617% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -227.589% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 80800.0% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -43.129% |
| GRI Bio, Inc. | 10.84 Million USD | -1150.586% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -5237.667% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1660.677% |
| IGM Biosciences, Inc. | -211.66 Million USD | 164.054% |
| INmune Bio, Inc. | 155 Thousand USD | -87368.387% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -118.886% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9100.651% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21007.574% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 463227.69% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -33625.373% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 6892.385% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 43415.016% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -43.526% |
| Verastem, Inc. | -62 Thousand USD | 218770.968% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -5467.803% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 52044.828% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -4378.89% |
| Histogen Inc. | 3.76 Million USD | -3497.135% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -23430.188% |
| Surrozen, Inc. | -27.23 Million USD | 597.892% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2615.791% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 11352.241% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 628.623% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -576.122% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 6847372.727% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -2134.859% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 202057.367% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 12.414% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -92887.654% |
| Apollomics, Inc. | 127 Thousand USD | -106652.756% |
| Amarin Corporation plc | 165.54 Million USD | 18.101% |
| Mesoblast Limited | -9.81 Million USD | 1481.314% |
| Turnstone Biologics Corp. | 16.5 Million USD | -721.374% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 222.705% |
| Synaptogenix, Inc. | -6347.00 USD | 2136164.282% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 265935.294% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 15.982% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 92.287% |
| Better Therapeutics, Inc. | -2.72 Million USD | 5067.974% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 220.876% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 59.898% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1188529.173% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 2265.751% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12336.101% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1752.637% |
| Insmed Incorporated | 239.63 Million USD | 43.424% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -3689.156% |
| OmniAb, Inc. | 14.66 Million USD | -824.361% |
| Alector, Inc. | -95.05 Million USD | 242.632% |
| Seres Therapeutics, Inc. | 125.62 Million USD | -7.925% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 411.934% |
| Zai Lab Limited | 170.9 Million USD | 20.671% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -65.585% |
| Aura Biosciences, Inc. | -1.29 Million USD | 10569.189% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -104189.231% |
| Immunic, Inc. | -111 Thousand USD | 122240.541% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -755.153% |
| Veracyte, Inc. | 248.14 Million USD | 45.365% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.94% |
| FibroGen, Inc. | 128.9 Million USD | -5.176% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 24038397.872% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 1262.058% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.011% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -34752.442% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 61.847% |
| TG Therapeutics, Inc. | 219.1 Million USD | 38.124% |
| Galecto, Inc. | -830 Thousand USD | 16434.458% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 9888.881% |
| Fortrea Holdings Inc. | 424 Million USD | 68.025% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 257.341% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 24011.111% |
| XBiotech Inc. | -1.74 Million USD | 7873.853% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 12336.101% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 391.743% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 279.49% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -84.701% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -706.856% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 65.151% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 373.08% |
| Vaxxinity, Inc. | -2.23 Million USD | 6168.756% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 58.508% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1297.261% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -454.48% |
| NexImmune, Inc. | -1.02 Million USD | 13327.288% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -2510566.667% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 2008.001% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 98.8% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 202976.083% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3917.967% |
| Ainos, Inc. | -253.73 Thousand USD | 53532.545% |
| Pluri Inc. | 322 Thousand USD | -42004.348% |
| Prothena Corporation plc | -129.2 Million USD | 204.934% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -168.872% |
| Celularity Inc. | 6.75 Million USD | -1907.047% |
| Rallybio Corporation | -150 Thousand USD | 90484.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | 515.788% |
| MeiraGTx Holdings plc | 287 Thousand USD | -47139.024% |
| Omeros Corporation | -69.77 Million USD | 294.293% |
| Humacyte, Inc. | -76.55 Million USD | 277.108% |
| Immunocore Holdings plc | 248.39 Million USD | 45.418% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 993.77% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -117.332% |
| Blueprint Medicines Corporation | 236.58 Million USD | 42.694% |
| CalciMedica, Inc. | -58 Thousand USD | 233851.724% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 9607.433% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -366.618% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 4867.089% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 539.255% |
| Pulmatrix, Inc. | -8.22 Million USD | 1749.343% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 11687.692% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 34078.947% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 133.996% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -4784.592% |
| Cytokinetics, Incorporated | -322.59 Million USD | 142.027% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -15626.159% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 39858.358% |
| Vor Biopharma Inc. | -3.49 Million USD | 3982.474% |
| Roivant Sciences Ltd. | 109.23 Million USD | -24.114% |
| Evogene Ltd. | 1.39 Million USD | -9590.922% |
| ProKidney Corp. | -3.16 Million USD | 4378.195% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 408.745% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1877.191% |
| CorMedix Inc. | -205.56 Thousand USD | 66053.824% |
| BioLineRx Ltd. | 1.1 Million USD | -12136.101% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 272.333% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 410936.364% |
| Atai Life Sciences N.V. | -5000.00 USD | 2711620.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 111356.452% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 141325.0% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 9860.691% |
| Sagimet Biosciences Inc. | 2 Million USD | -6678.8% |
| MediciNova, Inc. | 979.7 Thousand USD | -13738.451% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 260.789% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 143483.216% |
| GeoVax Labs, Inc. | -20.72 Million USD | 754.3% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 44.558% |
| Biomea Fusion, Inc. | -4.2 Million USD | 3327.232% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 84.458% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1725.694% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 43834.194% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 1129900.0% |
| Absci Corporation | -41.84 Million USD | 423.965% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2711620.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 277.518% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 5608.98% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 36.568% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 14507.651% |
| Allakos Inc. | -6.14 Million USD | 2307.719% |
| Imunon, Inc. | -720 Thousand USD | 18929.869% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 296.498% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 71.511% |
| BioAtla, Inc. | -103.73 Million USD | 230.7% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 1188529.173% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 76266.292% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 155.834% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 43693.569% |
| XOMA Corporation | 3.86 Million USD | -3411.422% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 293.445% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -816.426% |
| aTyr Pharma, Inc. | -2.38 Million USD | 5777.387% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -988.09% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 467603.448% |
| Viridian Therapeutics, Inc. | -1 Million USD | 13550.0% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -1042892207.692% |
| Akari Therapeutics, Plc | -4000.00 USD | 3389500.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 78.713% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -69530.421% |
| UroGen Pharma Ltd. | 73.35 Million USD | -84.829% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 607.889% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -1167651.938% |
| Orgenesis Inc. | -5.72 Million USD | 2468.14% |
| Entera Bio Ltd. | -56 Thousand USD | 242200.0% |
| GH Research PLC | -315 Thousand USD | 43140.0% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 71833.333% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 25924.0% |
| Xencor, Inc. | -85.26 Million USD | 259.015% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 61452.991% |
| Replimune Group, Inc. | -2.65 Million USD | 5206.441% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 13640.863% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 23.767% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -69530.421% |
| Portage Biotech Inc. | -54 Thousand USD | 251166.667% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 143483.216% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 36061.804% |
| OncoCyte Corporation | 413 Thousand USD | -32727.119% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 3016251.279% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 61070370.27% |
| Purple Biotech Ltd. | -196 Thousand USD | 69271.429% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1411.775% |
| scPharmaceuticals Inc. | 9.78 Million USD | -1285.974% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1398.004% |
| HilleVax, Inc. | -2.15 Million USD | 6388.312% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 139869.072% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 903699.04% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 20395.808% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 589560.87% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1806296.511% |
| Savara Inc. | -44.26 Million USD | 406.303% |
| Curis, Inc. | 9.81 Million USD | -1281.877% |
| Daré Bioscience, Inc. | 2.76 Million USD | -4795.285% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 108745.062% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 7941.296% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 59563.158% |
| BeiGene, Ltd. | 2.07 Billion USD | 93.478% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 4949.1% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 133.922% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -139.162% |
| Erasca, Inc. | -3.73 Million USD | 3732.797% |
| bluebird bio, Inc. | -4.03 Million USD | 3464.169% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 480559.281% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 92.881% |
| DBV Technologies S.A. | 15.72 Million USD | -762.004% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 480559.281% |
| Moderna, Inc. | 2.15 Billion USD | 93.709% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 14917.049% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1593.43% |
| Molecular Templates, Inc. | 50.39 Million USD | -169.027% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 25394.03% |
| Travere Therapeutics, Inc. | 133.78 Million USD | -1.336% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 2278.978% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 444.6% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 222.0% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3878.595% |
| MacroGenics, Inc. | 50.52 Million USD | -168.324% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 2323.286% |
| Prime Medicine, Inc. | -147.9 Million USD | 191.664% |
| Aditxt, Inc. | -111.66 Thousand USD | 121518.592% |
| Adagene Inc. | 18.11 Million USD | -648.563% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -27681.967% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 3.3% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 14.103% |
| SciSparc Ltd. | 2.19 Million USD | -6073.77% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 541343.163% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 437696.023% |
| Generation Bio Co. | -73.91 Million USD | 283.431% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 31124.256% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -148.221% |
| Invivyd, Inc. | -2.02 Million USD | 6785.207% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 145.066% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 131169.82% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -40.686% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -37.937% |
| ADMA Biologics, Inc. | 88.21 Million USD | -53.683% |
| Clene Inc. | 533 Thousand USD | -25336.398% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -462.342% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 14266.771% |
| GeoVax Labs, Inc. | -20.72 Million USD | 754.3% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -6719.718% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 69870.889% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -172.214% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 2011.675% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 16317.225% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -62.532% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -185336.043% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -155.024% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 178.283% |
| Trevena, Inc. | 1.45 Million USD | -9217.938% |
| Surrozen, Inc. | -27.23 Million USD | 597.892% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 38506.799% |
| Cingulate Inc. | -582.91 Thousand USD | 23358.16% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 437441.935% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 788.238% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1791064.333% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 15488.876% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 80.083% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 13822.267% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 240730.436% |
| Kronos Bio, Inc. | 1.37 Million USD | -9781.633% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 352.629% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 46530.137% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 27864.103% |
| ImmunityBio, Inc. | -17.89 Million USD | 857.831% |
| Korro Bio, Inc. | -3.63 Million USD | 3834.876% |
| Kineta, Inc. | 5.43 Million USD | -2395.417% |
| BioVie Inc. | -229.37 Thousand USD | 59206.188% |
| Codexis, Inc. | 57.33 Million USD | -136.467% |
| Celularity Inc. | 6.75 Million USD | -1907.047% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -3278.42% |
| Celcuity Inc. | -142.77 Thousand USD | 95059.796% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -267889.721% |
| Cibus, Inc. | 1.42 Million USD | -9434.177% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 36350.267% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 691.544% |
| IN8bio, Inc. | -2.5 Million USD | 5520.872% |
| Kodiak Sciences Inc. | -25.94 Million USD | 622.511% |
| Annexon, Inc. | -3.26 Million USD | 4249.862% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 6732.877% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 424.834% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -21083.75% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 82.585% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 21.612% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 7235.579% |
| Arcellx, Inc. | 108.27 Million USD | -25.21% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 518.845% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -71.173% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 740.961% |
| Moolec Science SA | -143.3 Thousand USD | 94706.608% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 420.374% |
| Geron Corporation | -123.5 Million USD | 209.775% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -4024.612% |
| Royalty Pharma plc | 1.79 Billion USD | 92.442% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 293.431% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 3753588.372% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -58491.734% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 221.687% |
| Humacyte, Inc. | -76.55 Million USD | 277.108% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 14383.577% |
| 89bio, Inc. | -273 Thousand USD | 49761.538% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 10885.68% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 16087.736% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 110324.39% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -12015.818% |
| Notable Labs, Ltd. | 113 Thousand USD | -119878.761% |
| Liquidia Corporation | 14.6 Million USD | -828.603% |
| Mustang Bio, Inc. | -2.22 Million USD | 6193.303% |
| Immunovant, Inc. | -231 Thousand USD | 58790.909% |
| Quantum-Si incorporated | 488 Thousand USD | -27681.967% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 344.022% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 452020.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -7181.203% |
| Acasti Pharma Inc. | -11 Thousand USD | 1232609.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 66358.424% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 21007.574% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 180.935% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -11849.444% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 35684.252% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 7024.208% |
| PepGen Inc. | -1.18 Million USD | 11550.676% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 106852.756% |
| United Therapeutics Corporation | 2.07 Billion USD | 93.45% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 692.113% |
| Solid Biosciences Inc. | -76.56 Million USD | 277.078% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 164269.381% |
| Immuneering Corporation | -764.13 Thousand USD | 17842.345% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -204499.783% |
| Belite Bio, Inc | -399 Thousand USD | 34078.947% |
| XOMA Corporation | 3.86 Million USD | -3411.422% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 776.662% |
| Bionomics Limited | -434.44 Thousand USD | 31306.425% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12723.464% |
| uniQure N.V. | 2.21 Million USD | -6020.813% |
| Cassava Sciences, Inc. | -89.42 Million USD | 251.612% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 247.255% |
| Forte Biosciences, Inc. | -9000.00 USD | 1506500.0% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 16336.647% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 31124.256% |
| Altimmune, Inc. | -65.37 Million USD | 307.388% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 62.551% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 12723.464% |
| Compugen Ltd. | 31.45 Million USD | -331.016% |
| Peak Bio, Inc. | 367.76 Thousand USD | -36764.445% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -453.01% |
| Benitec Biopharma Inc. | 108 Thousand USD | -125433.333% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 173915.385% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 11369.825% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 7541.054% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 114029.412% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 11369.825% |
| Instil Bio, Inc. | -4.75 Million USD | 2950.631% |
| argenx SE | 1.1 Billion USD | 87.769% |
| Immunome, Inc. | -8.9 Million USD | 1622.129% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 7273.333% |
| Verona Pharma plc | -679.62 Thousand USD | 20048.678% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 77572.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | 5784.528% |
| CervoMed Inc. | -1.29 Million USD | 10580.301% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 5732.572% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2938.099% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -5386.686% |
| Moolec Science SA | -143.3 Thousand USD | 94706.608% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 33326.969% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 5174.849% |
| AnaptysBio, Inc. | 14.78 Million USD | -817.232% |
| Design Therapeutics, Inc. | -537 Thousand USD | 25346.927% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 31850.82% |
| NeurAxis, Inc. | 2.15 Million USD | -6186.259% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -6217.614% |
| Lumos Pharma, Inc. | 2 Million USD | -6655.157% |
| Achilles Therapeutics plc | -4.73 Million USD | 2965.533% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 77572.0% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 128395.245% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -328.242% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -15626.159% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 13237.209% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 397.655% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -315193.023% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 16593.431% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 1030469.357% |
| Palisade Bio, Inc. | 246 Thousand USD | -55012.195% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 410936.364% |
| Beam Therapeutics Inc. | -59.67 Million USD | 327.202% |
| Neurogene Inc. | -3.26 Million USD | 4256.223% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 2.698% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 3772.156% |
| Sesen Bio, Inc. | 40 Million USD | -238.94% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 45748.485% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 3466.644% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1517.269% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -862.898% |
| Athira Pharma, Inc. | -969 Thousand USD | 14091.331% |
| Vaccinex, Inc. | -16 Million USD | 947.138% |
| HCW Biologics Inc. | -574.82 Thousand USD | 23685.654% |
| XOMA Corporation | 3.86 Million USD | -3411.422% |
| Nektar Therapeutics | 53.47 Million USD | -153.517% |
| Arvinas, Inc. | 71.8 Million USD | -88.825% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 262.442% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 315.971% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 42204.348% |
| Rezolute, Inc. | -36 Thousand USD | 376700.0% |
| Clene Inc. | 533 Thousand USD | -25336.398% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 10558978.505% |
| BeyondSpring Inc. | 1.75 Million USD | -7642.776% |
| Synlogic, Inc. | -1.92 Million USD | 7146.57% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 366521.622% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 2241.124% |
| Peak Bio, Inc. | 367.76 Thousand USD | -36764.445% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 814.95% |
| Krystal Biotech, Inc. | 47.6 Million USD | -184.794% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 3.909% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -2598.03% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 5336.174% |
| MannKind Corporation | 136.19 Million USD | 0.452% |
| Ikena Oncology, Inc. | -50.49 Million USD | 368.51% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | -24.594% |
| Gossamer Bio, Inc. | -4.38 Million USD | 3191.813% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 53900.0% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2711620.0% |
| Legend Biotech Corporation | 140.92 Million USD | 3.798% |
| Mural Oncology plc | -2.56 Million USD | 5381.496% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 24705.445% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 135676.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -553.252% |
| REGENXBIO Inc. | 53.02 Million USD | -155.664% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2630.842% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 70574.854% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 7927.714% |
| Vaxart, Inc. | -60.76 Million USD | 323.123% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 51692.968% |
| Cellectis S.A. | 18 Thousand USD | -753100.0% |
| Longeveron Inc. | 221 Thousand USD | -61246.606% |
| Repare Therapeutics Inc. | -80.07 Million USD | 269.322% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 87.596% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 10577.28% |
| Revolution Medicines, Inc. | -399.66 Million USD | 133.922% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 387460.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -276585.714% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.425% |
| Denali Therapeutics Inc. | -93.34 Million USD | 245.242% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 541343.163% |
| Veru Inc. | 7.56 Million USD | -1691.928% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 89885.43% |
| Cingulate Inc. | -582.91 Thousand USD | 23358.16% |
| Passage Bio, Inc. | -3.72 Million USD | 3743.537% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 1125772.534% |
| Exicure, Inc. | -1.42 Million USD | 9627.477% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 35498.433% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -4915.76% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 26544.824% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -99.008% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 90721.428% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 328.99% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -34574.169% |
| OmniAb, Inc. | 14.66 Million USD | -824.361% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -578.117% |
| Lipocine Inc. | -2.85 Million USD | 4855.688% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 7456.267% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 2476.442% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 9100.651% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -80.01% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 208678.462% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -60.833% |
| Ocugen, Inc. | -33.53 Million USD | 504.258% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 4387.666% |
| Q32 Bio Inc. | 578 Thousand USD | -23356.055% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 51260.755% |
| Alumis Inc. Common Stock | -1.28 Million USD | 10658.879% |
| Equillium, Inc. | 35.95 Million USD | -277.04% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 8042.355% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -26978.427% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 3279635.559% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 52445.946% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -31972.901% |
| Dominari Holdings Inc. | 2.03 Million USD | -6549.142% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 73995.057% |
| vTv Therapeutics Inc. | -13.59 Million USD | 1097.249% |
| Bio-Techne Corporation | 773.07 Million USD | 82.463% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -682.817% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 70.577% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 11697.605% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 665.371% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -1059.066% |
| Nkarta, Inc. | -5.86 Million USD | 2410.036% |
| BioCardia, Inc. | -7.24 Million USD | 1970.272% |
| Iterum Therapeutics plc | -1.75 Million USD | 7847.2% |